Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI109328

Resting Skeletal Muscle Membrane Potential as an Index of Uremic Toxicity: A PROPOSED NEW METHOD TO ASSESS ADEQUACY OF HEMODIALYSIS

James R. Cotton, Terry Woodard, Norman W. Carter, and James P. Knochel

Veterans Administration Medical Center, University of Texas Health Science Center, Dallas, Texas 75235

Department of Internal Medicine, University of Texas Health Science Center, Dallas, Texas 75235

Find articles by Cotton, J. in: PubMed | Google Scholar

Veterans Administration Medical Center, University of Texas Health Science Center, Dallas, Texas 75235

Department of Internal Medicine, University of Texas Health Science Center, Dallas, Texas 75235

Find articles by Woodard, T. in: PubMed | Google Scholar

Veterans Administration Medical Center, University of Texas Health Science Center, Dallas, Texas 75235

Department of Internal Medicine, University of Texas Health Science Center, Dallas, Texas 75235

Find articles by Carter, N. in: PubMed | Google Scholar

Veterans Administration Medical Center, University of Texas Health Science Center, Dallas, Texas 75235

Department of Internal Medicine, University of Texas Health Science Center, Dallas, Texas 75235

Find articles by Knochel, J. in: PubMed | Google Scholar

Published March 1, 1979 - More info

Published in Volume 63, Issue 3 on March 1, 1979
J Clin Invest. 1979;63(3):501–506. https://doi.org/10.1172/JCI109328.
© 1979 The American Society for Clinical Investigation
Published March 1, 1979 - Version history
View PDF
Abstract

Electrochemical disturbances of skeletal muscle cells in untreated uremia are characterized by an increase in the intracellular sodium and chloride content, a decrease in intracellular potassium, and a low resting membrane potential. In this study, we have reexamined the foregoing and, in addition, have examined the effects of hemodialysis. Three groups of patients were studied. In the first group of 22 uncomplicated uremic patients, whose creatinine clearance (Ccr) ranged from 2 to 12 cm3/min per 1.73 m2, resting transmembrane potential difference (Em) of skeletal muscle cells was measured. In each of the nine patients whose Ccr ranged between 6.3 and 12 cm3/min, the Em was normal (i.e., −90.8±0.9 mV, mean±SEM). However, as Ccr dropped below 6.3 cm/min, the Em became progressively reduced and assumed a linear relationship with the Ccr.

In the second study, nine individuals with end-stage renal disease, whose mean Ccr was 4.3 cm3/min, underwent measurement of Em and intracellular electrolyte concentration before and after 7 wk of hemodialysis. Before dialysis, the Em was −78.5±2.1 mV, intracellular sodium and chloride were elevated, and the intracellular potassium was reduced. After 7 wk of hemodialysis the Em rose to −87.8±1.3 mV, and the intracellular sodium, chloride, and potassium became normal.

In the third study, seven patients who were stable on 6-h thrice-weekly dialysis were studied before and after reduction of dialysis to 6 h twice weekly. In those individuals whose Em remained normal after 6 wk, dialysis time was reduced further. On thrice-weekly dialysis the Em was −91.2±1.0 mV. With reduced dialysis, the Em fell to −80.1±0.8 mV (P < 0.001). In each case, the Em became abnormal before significant signs or symptoms of uremia were noted. These findings demonstrate that end-stage renal disease is associated with serious electrochemical changes in the muscle cell which are reversed by hemodialysis and recur when dialysis time is reduced. Thus, serial observations of muscle Em may be a potentially powerful tool to assess adequacy of dialysis therapy.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 501
page 501
icon of scanned page 502
page 502
icon of scanned page 503
page 503
icon of scanned page 504
page 504
icon of scanned page 505
page 505
icon of scanned page 506
page 506
Version history
  • Version 1 (March 1, 1979): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts